AB Science Provides Update on P-II Trial Design of Masitinib for COVID-19
Shots: The P-II (AB20001) trial was designed to assess masitinib + isoquercetin in...
Pfizer and BioNTech Report the CHMP’s Positive Opinion of Comirnaty JN.1 Vaccine for COVID-19
Shots: The CHMP has granted positive opinion to Omicron JN.1-adapted COVID-19 vacc...
The EC Approves Biogen’s Tofidence (Biosimilar, Roactemra) for Treating Arthritis and COVID-19
Shots: The EC has approved Tofidence (IV), a biosimilar version of Roactemra, to t...
AstraZeneca Reports Results from the P-III (SUPERNOVA) Study of Sipavibart to Prevent COVID-19 in Immunocompromised Patients
Shots: The P-III (SUPERNOVA) study investigates the safety & efficacy of sipav...
Sanofi Partners with Novavax to Co-commercialize COVID-19 Vaccine and Develop Flu-COVID-19 Combination Vaccines
Shots: Agreement grants co-exclusive rights to Sanofi to co-commercialize Novavax&...
